SARS-CoV-2 Dual Target by RT-PCR
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000592489.5
- Last updated: 2023-10-16
- Test version history
Clinical microbial testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for COVID-19
Offered by MAWD Laboratories
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.SARS-CoV-2 Dual Target by RT-PCR
This is a clinical microbial test intended for HelpPurposes or indications for the test. Lab-provided.: Screening, Diagnosis
Click Indication tab for more information.
Not provided
Specimen source
Sample requirements
Nasopharyngeal swab samples should be preserved and transported in viral transport media. Specimens are stable at refrigerated temperature (2-8 degrees C) or at room temperature up to 72 hours.Turnaround time
1-2 daysMethodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Molecular Genetics
- RRNA analysis
- RT-PCR
- Applied Biosystems Real Time PCR systems
Not provided
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Not provided
Comments about the test interpretation (e.g. clinical implication of test results)
A positive result is indicative of the presence of SARS-CoV-2 RNA but does not rule out bacterial infection or co-infection with other viruses. A negative result does not definitively rule out SARS-CoV-2 infection and should be combined with clinical observations, patient history, and epidemiological information when making clinical decisions.IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.